Viewing Study NCT02447666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2026-01-31 @ 1:17 PM
Study NCT ID: NCT02447666
Status: COMPLETED
Last Update Posted: 2019-07-11
First Post: 2015-04-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Juvenile Myelomonocytic Leukemia (JMML)
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Leukemia, Myelomonocytic, Juvenile View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Azacitidine View
None Myelodysplastic syndrome View
None Juvenile myelomonocytic leukemia View
None Hematopoietic stem cell transplantation View
None Vidaza View
None Hypomethylating agent View